IGC Pharma, Inc.
AMEX: IGC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ram Mukunda
- Employees
- 67
- Headquarters
- Potomac, United States
- IPO year
- 2006
- Market cap
- $27.5M
- Website
- https://igcpharma.com
Loading IGC…
Loading profile data…Frequently asked questions about IGC
What does IGC Pharma, Inc. (IGC) do?
IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing...
Where does IGC trade?
IGC Pharma, Inc. (IGC) trades on the New York Stock Exchange American.
What sector is IGC in?
IGC Pharma, Inc. (IGC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IGC Pharma, Inc.?
Ram Mukunda is the chief executive officer of IGC Pharma, Inc. (IGC).
Where is IGC Pharma, Inc. headquartered?
IGC Pharma, Inc. is headquartered in United States.
Does IGC pay a dividend?
IGC Pharma, Inc. (IGC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IGC go public?
IGC Pharma, Inc. (IGC) completed its initial public offering in 2006.